Idilla

Dienogest/Estradiol Valerate, the active ingredient in Idilla, is a combined oral contraceptive presented as an oral tablet for oral use. It provides hormonal contraception and helps regulate the menstrual cycle in women of reproductive age.

GNH USA supplies Idilla as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Idilla, a combined oral contraceptive, is used to manage hormonal contraception and menstrual cycle regulation.

- Contraception: Prevents pregnancy by inhibiting ovulation and altering cervical mucus. - Menstrual cycle regulation: Reduces irregular bleeding and stabilises cycle length. - Endometriosis‑related pain: Alleviates pain associated with endometriosis by suppressing estrogen‑driven tissue growth.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: temporary swelling or discomfort. - Spotting or breakthrough bleeding: irregular light bleeding. - Weight change: slight increase or decrease. - Mood changes: irritability or mild depressive symptoms.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Stroke or transient ischaemic attack. - Myocardial infarction: heart attack risk, especially in smokers. - Severe allergic reaction: anaphylaxis, rash, or angioedema. - Liver dysfunction: jaundice or abnormal liver enzymes. - Hyperglycaemia: elevated blood sugar in susceptible individuals.

Before prescribing Idilla, clinicians should evaluate individual risk factors and contraindications. - Pregnancy: contraindicated (Category X); do not use during pregnancy. - Smoking: avoid in women over 35 who smoke due to increased cardiovascular risk. - Cardiovascular disease: assess history of thromboembolism, stroke, or myocardial infarction. - Liver disease: use with caution in patients with hepatic impairment. - Migraine with aura: avoid because of heightened stroke risk. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Idilla may interact with several medicines that alter hormone metabolism or clotting pathways.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): markedly reduce contraceptive efficacy. - Anticoagulants (e.g., warfarin): may increase risk of thrombosis. - Certain antiepileptics (e.g., phenytoin): decrease hormone levels, compromising contraception.

Moderate Interactions (Monitor Closely): - Antibiotics such as tetracycline or metronidazole: possible modest reduction in effectiveness. - Herbal supplements (e.g., St. John's wort): may lower plasma hormone concentrations. - Antifungal agents (e.g., ketoconazole): can raise hormone levels, increasing side‑effect risk.